Our sustained top-tier global ranking reflects our leadership in both clinical care and neuroscience research. As a core site for international clinical trials, we contribute to the advancement of treatments across a wide range of neurological diseases, including stroke, Alzheimer’s disease, Parkinson’s disease, epilepsy, amyotrophic lateral sclerosis, and multiple sclerosis. We also provide dedicated programs for rare and treatment-resistant neurological disorders, supported by robust research infrastructure and specialized clinical protocols.

Our translational research efforts aim to apply scientific discoveries efficiently to patient care, ensuring timely access to emerging diagnostics and therapies. Our Neurological Emergency Team (NET) provides 24/7 expert coverage for acute neurological conditions, ensuring immediate and effective response throughout the hospital.

We operate a dedicated Neurology Intensive Care Unit (NRICU) equipped with advanced monitoring and treatment protocols and lead pioneering educational programs that set new standards in neurological intensive care. These integrated emergency and critical care services significantly improve patient outcomes in neurological crises.

Our commitment to global neurological care is reflected in our comprehensive international programs. We provide specialized medical services for international patients and support overseas medical student exchange and training programs that promote collaboration and knowledge sharing across borders. Our research partnerships extend across multiple countries, advancing scientific understanding of neurological conditions in diverse populations.

Through these multifaceted efforts, our Department of Neurology continues to lead global neurological care by delivering innovative treatments, conducting world-class research, and providing compassionate patient-centered care that serves individuals from all backgrounds and with diverse conditions.